Literature DB >> 33836883

Discharge Disposition Following Hematopoietic Cell Transplantation: Predicting the Need for Rehabilitation and Association with Survival.

Sarah A Wall1, Qiuhong Zhao2, Sumithira Vasu2, Ashley Rosko2.   

Abstract

Many hematopoietic cell transplantation (HCT) recipients require rehabilitation due to deconditioning following intensive conditioning regimens and immune reconstitution. HCT recipients are preferentially discharged to home to avoid the risk of exposure to healthcare-associated infection in a rehabilitation facility (RF), with a caregiver who has been provided specific education about the complexity of post-HCT care. This study was conducted to determine the incidence of discharge to an RF following HCT, identify pre-HCT and peri-HCT risk factors for discharge to an RF, and estimate the effect of discharge disposition on overall survival (OS). This retrospective, matched 1:4 case-control study included 56 cases over a 10-year period from a single institution. Controls were matched by transplantation type (autologous versus allogeneic) and date of transplantation. The incidence of discharge to an RF was 2.2%. Controlling for disease, increasing age (odds ratio [OR], 1.09; 95% confidence interval [CI], 1.04 to 1.15; P < .001), female sex (OR, 3.11; 95% CI, 1.32 to 7.32; P = .01), high-risk HCT Comorbidity Index (HCT-CI) score (≥3) (OR, 3.44; 95% CI, 1.39 to 8.52; P = .008), decreasing pre-HCT serum albumin (OR, 2.60; 95% CI, 1.07 to 6.38; P = .037), and development of acute kidney injury during HCT (OR, 4.10; 95% CI, 1.36 to 12.40; P = .012) were associated with discharge to an RF. Discharge to an RF was associated with worse OS and higher nonrelapse mortality (NRM) compared with discharge to home (1-year OS, 70.5% [95% CI, 55.8% to 81.1%] versus 88.8% [95% CI, 83.6% to 92.4%], P < .001; 100-day NRM: 9.5% [95% CI, 3.5% to 19.2%] versus 1.8% [95% CI, 0.6% to 4.3%]; P = .03). Discharge to an RF following HCT is a rare event but associated with poor OS. Modifiable risk factors for discharge to an RF, including serum albumin as a measure of nutrition and reversible HCT-CI components, should be prospectively studied to determine the effect of mitigation on discharge disposition and survival.
Copyright © 2020 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hematopoietic cell transplantation (HCT); hematopoietic cell transplantation comorbidity index (HCT-CI); rehabilitation; rehabilitation facility; skilled nursing facility (SNF)

Mesh:

Year:  2020        PMID: 33836883      PMCID: PMC8036236          DOI: 10.1016/j.jtct.2020.11.015

Source DB:  PubMed          Journal:  Transplant Cell Ther        ISSN: 2666-6367


  21 in total

1.  Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score.

Authors:  Martine Extermann; Ivette Boler; Richard R Reich; Gary H Lyman; Richard H Brown; Joseph DeFelice; Richard M Levine; Eric T Lubiner; Pablo Reyes; Frederic J Schreiber; Lodovico Balducci
Journal:  Cancer       Date:  2011-11-09       Impact factor: 6.860

2.  Infectious disease outbreaks in nursing homes: an unappreciated hazard for frail elderly persons.

Authors:  Larry J Strausbaugh; Shirin R Sukumar; Carol L Joseph
Journal:  Clin Infect Dis       Date:  2003-03-19       Impact factor: 9.079

Review 3.  The Biology of Aging and Cancer: Frailty, Inflammation, and Immunity.

Authors:  Xinwen Zhang; Xin Meng; Yiyin Chen; Sean X Leng; Haiyan Zhang
Journal:  Cancer J       Date:  2017 Jul/Aug       Impact factor: 3.360

4.  Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.

Authors:  Mohamed L Sorror; Michael B Maris; Rainer Storb; Frederic Baron; Brenda M Sandmaier; David G Maloney; Barry Storer
Journal:  Blood       Date:  2005-06-30       Impact factor: 22.113

Review 5.  Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer: a systematic review.

Authors:  Marije E Hamaker; Judith M Jonker; Sophia E de Rooij; Alinda G Vos; Carolien H Smorenburg; Barbara C van Munster
Journal:  Lancet Oncol       Date:  2012-10       Impact factor: 41.316

6.  Autologous hematopoietic stem cell transplant induces the molecular aging of T-cells in multiple myeloma.

Authors:  A Rosko; C Hofmeister; D Benson; Y Efebera; Y Huang; J Gillahan; J C Byrd; C E Burd
Journal:  Bone Marrow Transplant       Date:  2015-06-29       Impact factor: 5.483

7.  Predicting Potential Adverse Events During a Skilled Nursing Facility Stay: A Skilled Nursing Facility Prognosis Score.

Authors:  Robert E Burke; Edward Hess; Anna E Barón; Cari Levy; Jacques D Donzé
Journal:  J Am Geriatr Soc       Date:  2018-03-02       Impact factor: 5.562

8.  Functional Status as Measured by Geriatric Assessment Predicts Inferior Survival in Older Allogeneic Hematopoietic Cell Transplantation Recipients.

Authors:  Li-Wen Huang; Ying Sheng; Charalambos Andreadis; Aaron C Logan; Gabriel N Mannis; Catherine C Smith; Karin M L Gaensler; Thomas G Martin; Lloyd E Damon; Michael A Steinman; Chiung-Yu Huang; Rebecca L Olin
Journal:  Biol Blood Marrow Transplant       Date:  2019-09-05       Impact factor: 5.742

9.  Low serum albumin levels prior to pediatric allogeneic HCT are associated with increased need for critical care interventions and increased 6-month mortality.

Authors:  Alicia M Teagarden; Jodi L Skiles; Andrew L Beardsley; Michael J Hobson; Elizabeth A S Moser; Jamie L Renbarger; Courtney M Rowan
Journal:  Pediatr Transplant       Date:  2017-07-02

Review 10.  International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer.

Authors:  Hans Wildiers; Pieter Heeren; Martine Puts; Eva Topinkova; Maryska L G Janssen-Heijnen; Martine Extermann; Claire Falandry; Andrew Artz; Etienne Brain; Giuseppe Colloca; Johan Flamaing; Theodora Karnakis; Cindy Kenis; Riccardo A Audisio; Supriya Mohile; Lazzaro Repetto; Barbara Van Leeuwen; Koen Milisen; Arti Hurria
Journal:  J Clin Oncol       Date:  2014-08-20       Impact factor: 44.544

View more
  1 in total

1.  Allogeneic hematopoietic cell transplantation for older patients.

Authors:  Richard J Lin; Andrew S Artz
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.